Medivir AB (publ)

MVRBF · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$88,765-$62,579-$42,620-$123,334
Dep. & Amort.$2,571$2,595$4,430$7,086
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$15,626$12,437-$2,295-$15,660
Other Non-Cash$0-$1,187-$17,568-$16,347
Operating Cash Flow-$101,820-$48,734-$58,053-$148,255
Investing Activities
PP&E Inv.-$382$0-$2,684-$1,436
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$6,346$4,427
Other Inv. Act.$0$0$1,706$1,499
Investing Cash Flow-$382$0$5,368$4,490
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$404$223,515$595$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,535$199,400-$12,118-$6,659
Financing Cash Flow-$1,535$199,400-$12,118-$6,659
Forex Effect$3$494$301-$1,349
Net Chg. in Cash-$103,733$151,160-$64,502-$151,773
Supplemental Information
Beg. Cash$221,167$70,007$134,509$286,282
End Cash$117,434$221,167$70,007$134,509
Free Cash Flow-$102,202-$48,734-$60,737-$149,691